Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank.
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Among authors: machado mj. Microbiol Resour Announc. 2021 Jan 7;10(1):e01011-20. doi: 10.1128/MRA.01011-20. Microbiol Resour Announc. 2021. PMID: 33414286 Free PMC article.
Difficult-To-Detect Staphylococcus aureus: mecA-Positive Isolates Associated with Oxacillin and Cefoxitin False-Susceptible Results.
Gargis AS, Yoo BB, Lonsway DR, Anderson K, Campbell D, Ewing TO, Lawsin A, Machado MJ, Yamamoto N, Halpin AL, Lutgring JD, Karlsson M, Rasheed JK, Elkins CA. Gargis AS, et al. Among authors: machado mj. J Clin Microbiol. 2020 Mar 25;58(4):e02038-19. doi: 10.1128/JCM.02038-19. Print 2020 Mar 25. J Clin Microbiol. 2020. PMID: 31996449 Free PMC article. No abstract available.
Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales.
Bhatnagar A, Ransom EM, Machado MJ, Boyd S, Reese N, Anderson K, Lonsway D, Elkins CA, Rasheed JK, Patel JB, Karlsson M, Brown AC, Lutgring JD. Bhatnagar A, et al. Among authors: machado mj. J Antimicrob Chemother. 2021 Mar 12;76(4):979-983. doi: 10.1093/jac/dkaa531. J Antimicrob Chemother. 2021. PMID: 33367916 Free PMC article.
Characterization of the First Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate Harboring blaSIM-1 from the United States.
Prussing C, Canulla T, Singh N, McAuley P, Gosciminski M, King E, Bandy U, Machado MJ, Karlsson M, Musser KA, Huard RC, Nazarian EJ. Prussing C, et al. Among authors: machado mj. Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0106621. doi: 10.1128/AAC.01066-21. Epub 2021 Aug 2. Antimicrob Agents Chemother. 2021. PMID: 34339276 Free PMC article. No abstract available.
Correction for Paulick et al., "Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank".
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Among authors: machado mj. Microbiol Resour Announc. 2022 May 19;11(5):e0030222. doi: 10.1128/mra.00302-22. Epub 2022 Apr 27. Microbiol Resour Announc. 2022. PMID: 35475673 Free PMC article. No abstract available.
Antimicrobial Resistance Laboratory Network's multisite evaluation of the ThermoFisher Sensititre GN7F broth microdilution panel for antimicrobial susceptibility testing.
Bhatnagar AS, Machado M-J, Patterson L, Anderson K, Abelman RL, Bateman A, Biggs A, Bumpus-White P, Craft B, Howard M, LaVoie SP, Lonsway D, Sabour S, Schneider A, Snippes-Vagnone P, Tran M, Torpey D, Valley A, Elkins CA, Karlsson M, Brown AC. Bhatnagar AS, et al. J Clin Microbiol. 2023 Dec 19;61(12):e0079923. doi: 10.1128/jcm.00799-23. Epub 2023 Nov 16. J Clin Microbiol. 2023. PMID: 37971271 Free PMC article.
Complete genome sequences of Clostridioides difficile surveillance isolates representing the top 10 ribotypes from the Emerging Infections Program, United States, 2016.
Adamczyk M, Vlachos N, Breaker E, Orazi G, Paulick AL, Rowe LA, McAllister G, Machado M-J, Korhonen L, Guh AY, Rasheed JK, Karlsson M, McKay SL, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Adamczyk M, et al. Microbiol Resour Announc. 2024 Jul 18;13(7):e0112823. doi: 10.1128/mra.01128-23. Epub 2024 May 29. Microbiol Resour Announc. 2024. PMID: 38809010 Free PMC article.
64 results